Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
Regencell Bioscience (RGC) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $2.61B. Nama's AI scorecard rates it Hold. On 12-month momentum it ranks in the lagging band of its market.
AI scorecard
Hold
The sections balance. As of Nov 6, 2026.
Momentum
Lagging · -46.4% over 12 months ex. last
Second-worst fifth of its market on the past year's move.
Shariah screen
Can't Tell
A figure the screen needs is missing, so it can't tell.
Off its high
-93.7%
How far the last close sits under the highest price of the past five years.
Nama's AI scorecard currently rates Regencell Bioscience Hold, a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
Is RGC Shariah compliant?
Nama's AAOIFI-style screen reads Regencell Bioscience as Can't Tell. A figure the screen needs is missing, so it can't tell.